Australian biotech company AnteoTech (ASX: ADO) is preparing for clinical trials of a coronavirus test using just saliva samples.
The deets: AnteoTech’s COVID-19 test has been shown to detect traces of the virus in saliva. The product has met all requirements to move forward to the next developmental stage, which is on track to occur in December. If successful, the company will aim to fulfill the ongoing need for rapid COVID-19 testing through 2021.
Thoughts:Â The marketplace for COVID-19 management and vaccines is rapidly evolving with the virus sticking around for the foreseeable future. The traditional way of getting a test through a Q-Tip is very invasive, so a saliva breakthrough would be a significant improvement. Whether demand for these tests will remain after a vaccine is released and coronavirus is effectively eradicated remains to be seen.
Comments
Displaying 0 of 0 comments ( View all | Add Comment )